Ambu Financial Statements From 2010 to 2025

AMBBY Stock  USD 13.60  0.18  1.31%   
Ambu AS's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ambu AS's valuation are provided below:
Ambu AS does not presently have any fundamental signals for analysis.
Check Ambu AS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ambu AS's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ambu financial statements analysis is a perfect complement when working with Ambu AS Valuation or Volatility modules.
  
This module can also supplement various Ambu AS Technical models . Check out the analysis of Ambu AS Correlation against competitors.

Ambu AS Company Current Valuation Analysis

Ambu AS's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Ambu AS Current Valuation

    
  3.73 B  
Most of Ambu AS's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ambu AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Ambu AS has a Current Valuation of 3.73 B. This is 74.01% lower than that of the Healthcare sector and 69.95% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 77.54% higher than that of the company.

Ambu AS Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ambu AS's current stock value. Our valuation model uses many indicators to compare Ambu AS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambu AS competition to find correlations between indicators driving Ambu AS's intrinsic value. More Info.
Ambu AS is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ambu AS is roughly  1.67 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ambu AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ambu AS's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Ambu AS Financial Statements

Ambu AS investors use historical fundamental indicators, such as Ambu AS's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ambu AS. Please read more on our technical analysis and fundamental analysis pages.
Ambu AS develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. Ambu AS was founded in 1937 and is headquartered in Ballerup, Denmark. Ambu AS is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ambu Pink Sheet Analysis

When running Ambu AS's price analysis, check to measure Ambu AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ambu AS is operating at the current time. Most of Ambu AS's value examination focuses on studying past and present price action to predict the probability of Ambu AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ambu AS's price. Additionally, you may evaluate how the addition of Ambu AS to your portfolios can decrease your overall portfolio volatility.